Break it Down: EBR lands vital FDA approval

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Tylah Tully reveals all on EBR Systems (ASX:EBR), who have won US FDA approval for its WISE CRT system, the world’s first and only wireless solution for pacing the left side of the heart.

Watch the video to learn more.

 

While EBR Systems is a Stockhead advertiser, it did not sponsor this content.

Related Topics

Explore more

Explore more

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Read The Guide